Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Angiogenesis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02898077
What this trial is testing

Paclitaxel With or Without Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Cancer

Who this might be right for
Gastroesophageal Junction AdenocarcinomaGastric Adenocarcinoma
Eli Lilly and Company 440
Not applicableStudy completedNCT01543100
What this trial is testing

Prognostic Study of Markers of Angiogenesis and Coagulability in Patients With Monoclonal Gammopathy

Who this might be right for
Monoclonal GammopathyMonoclonal Gammopathy of Undetermined SignificationMyeloma
Rennes University Hospital 60
Early research (Phase 1)Study completedNCT01608009
What this trial is testing

[18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer

Who this might be right for
Ovarian Neoplasm
Imperial College London 16
Not applicableStudy completedNCT02159235
What this trial is testing

Heavy Metals, Angiogenesis Factors and Osteopontin in Coronary Artery Disease (CAD)

Who this might be right for
Ischemic Heart DiseaseCoronary Artery DiseaseHeavy Metal Toxicity
Medical University of Vienna 200
Not applicableUnknownNCT03474835
What this trial is testing

Ischemic Heart Disease in Male With Prostate Adenocarcinoma

Who this might be right for
Ischemic Heart DiseaseProstate Adenocarcinoma
Dnipropetrovsk State Medical Academy 100
Testing effectiveness (Phase 2)Study completedNCT00691379
What this trial is testing

Weekly Paclitaxel/Carboplatin/Bevacizumab as First Line Therapy for Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Hellenic Oncology Research Group 46
Testing effectiveness (Phase 2)Study completedNCT03013335
What this trial is testing

Nivolumab in Patients With Metastatic Renal Cell Carcinoma Who Have Progresses During or After Prior Systemic Anti-angiogenic Regimen

Who this might be right for
Metastatic Renal Cell Carcinoma
UNICANCER 730
Not applicableUnknownNCT05874115
What this trial is testing

Development of a Biomarker to Predict the Efficacy of Anti-angiogenic Therapy in Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
Centro di Riferimento Oncologico - Aviano 75
Testing effectiveness (Phase 2)Ended earlyNCT01239355
What this trial is testing

MK2206 in Treating Patients With Advanced Liver Cancer That Did Not Respond to Previous Therapy

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaLocalized Non-Resectable Adult Liver Carcinoma+1 more
National Cancer Institute (NCI) 15
Not applicableStudy completedNCT02334930
What this trial is testing

Evaluation of New Biomarkers Predictive of Efficacy Betablockers in PEComa and Vascular Pediatric Tumors

Who this might be right for
PEComaHemangioma
University Hospital, Bordeaux 13
Testing effectiveness (Phase 2)UnknownNCT00357617
What this trial is testing

Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery

Who this might be right for
Head and Neck Cancer
Centre Hospitalier Universitaire Vaudois 24
Large-scale testing (Phase 3)UnknownNCT02584478
What this trial is testing

Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002)

Who this might be right for
Endometrial CarcinomaOvarian CarcinomaFallopian Tube Carcinoma+2 more
Advenchen Laboratories, LLC 294
Early research (Phase 1)Study completedNCT01105533
What this trial is testing

A Dose Finding Study Of A New Medication, PF-00337210 That Will Possibly Decrease Blood Supply To Tumors

Who this might be right for
Neoplasm
Pfizer 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT06884345
What this trial is testing

METR-NK Cells in Combination With Anti-angiogenic Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer
Anhui Provincial Cancer Hospital 28
Not applicableEnded earlyNCT03203837
What this trial is testing

Biomarker Analyses in Hepatocellular Carcinoma (HCC) Patients Treated With TheraSphere®

Who this might be right for
Hepatocellular Carcinoma
Northwestern University 4
Not applicableUnknownNCT03225963
What this trial is testing

Application of Proteome Profiler Antibody Arrays to Find Angiogenetic Predictors in Glioma Paitents.

Who this might be right for
Glioblastoma MultiformeAngiogenesis
Taichung Veterans General Hospital 60
Testing effectiveness (Phase 2)Ended earlyNCT00850577
What this trial is testing

Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb 255
Large-scale testing (Phase 3)Looking for participantsNCT03902912
What this trial is testing

Effect of Prednisolone Treatment on Uterine Natural Killer Cells

Who this might be right for
Recurrent Miscarriage
Chinese University of Hong Kong 84
Post-approval studies (Phase 4)Study completedNCT01986907
What this trial is testing

Safety and Tolerability of Ranibizumab in Mono/Bilateral Wet Age Related Macular Degeneration (w-AMD) Patients in Eyes With BCVA<2/10 and/or 2nd Affected Eye

Who this might be right for
Wet Age Related Macular Degeneration
Novartis Pharmaceuticals 1,049
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07083375
What this trial is testing

A Phase II Study of QL1706 With Anti-angiogenesis Therapy and Chemotherapy in Extensive-stage Small Cell Lung Cancer.

Who this might be right for
Extensive Small Cell Lung Cancer
Zhijie Wang 56
Next Page